Search
Close this search box.

China’s pharmaceutical industry: from manufacturing hub to key R&D player

China's pharmaceutical industry

Since joining the World Trade Organization in 2001, China’s pharmaceutical industry has experienced remarkable growth. In 2021, it accounted for 12% of the global pharmaceutical market, second only to the United States, which accounted for a substantial 40% of the world’s total revenue. By 2022, despite challenges from the COVID-19 pandemic, the industry demonstrated resilience, […]

China’s mental health industry on the rise due to prolonged lockdowns

daxue-consulting-china-mental-health-market-cover

As lockdowns prolong in cities of China like Shanghai, people appear to be less high-spirited due to problems like food shortages and overpriced supplies, which potentially increase the demand for mental health services in China. The impact of long-period home quarantine could be detrimental to mental health, which could potentially lead to a serious mental […]

The crackdown on plastic surgery ads in China: Balancing the beauty economy with surgery scandals and deaths

plastic surgery ads in China

In September 2021, Chinese state media called for stricter regulations on plastic surgery ads in China, mentioning its excessive pervasiveness and false claims. In the last decade, China’s aesthetic medicine experienced a period of steady growth, driven by rising consumer disposable income, enhanced consumer awareness and the emergence of hedonic values. Chinese aesthetic medicine market […]

Digital healthcare in China: Powered by tech giants amid Covid-19 outbreak

digital healthcare in China

Digital healthcare is the integration of cutting-edge technologies such as the Internet of Things, big data, and artificial intelligence in the field of healthcare, which includes digitization, standardization and intelligence of medical consultation and pharmaceutical services.  The number of online medical users increased from 214.8 million in December 2020 to 233.33 million in Jun 2021, […]

Linking Chinese healthcare R&D and the Chinese healthcare industry with the rest of the world: China Paradigm transcript #124 with Douglas Corley

Chinese healthcare R&D

This transcript is based on our interview with Douglas Corley, an American healthcare entrepreneur and a bridge between Chinese healthcare R&D and western healthcare institutions. Douglas Corley is the founder and CEO of DHB Global in China. DHB Global provides clients with expert advice on the Chinese healthcare industry. Listen to the full episode of […]

Bayer in China: How the Pharma giant gained the strong approval of Chinese consumers

Bayer in China

Overview of Bayer and Bayer China Bayer AG is a global enterprise with core competencies in the life science fields of health care and agriculture. Bayer, headquartered in Leverkusen, Germany, is one of the most famous companies among the world’s top 500 enterprises. In 2019, the total number of Bayer’s employees was 103,824 and the […]

Telemedicine in China: Healthcare reaches a new status quo during the COVID-19 pandemic

telemedicine market in China

Data source: askCI.com- Market size of telemedicine in China from 2015-2019 Telemedicine consumer penetration Given the COVID-19 situation in the beginning of 2020, it is no surprise that the penetration rate jumped up by 2% YOY. By April 2019, the number of users of online telemedicine services in China had reached 45 million, with industry […]

The Traditional Chinese Medicine market: Boosted by COVID-19?

TCM market in China

Traditional Chinese Medicine takes 30-40% of China’s pharmaceutical market The Chinese pharmaceutical market consist of biologics, generics, OTC drugs, and traditional Chinese medicine. The traditional Chinese medicine market comprises about 30-40% of drug sales in China. It also displays more rapid growth than other segments of the pharmaceutical market in China. Yangtze River Pharmaceutical Group, […]